Stock Earnings

Question 1

What are eFFECTOR Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), eFFECTOR Therapeutics Inc has a total asset of $20, Net loss of $-35

Question 2

What are the key financial ratios for EFTR?

Accepted Answer

eFFECTOR Therapeutics Inc's Current ratio is 0.76, has a Net margin is 0, sales per share of $0.

Question 3

How is eFFECTOR Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Currently eFFECTOR Therapeutics Inc data is not available.

Question 4

Is eFFECTOR Therapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, eFFECTOR Therapeutics Inc has a net loss of $-35

Question 5

Does eFFECTOR Therapeutics Inc have any liabilities?

Accepted Answer

yes, eFFECTOR Therapeutics Inc has liability of 26

Question 6

How many outstanding shares for eFFECTOR Therapeutics Inc?

Accepted Answer

eFFECTOR Therapeutics Inc has a total outstanding shares of 2.98

Breakdown	TTM	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Revenue	0	0	3	1	42	0
Revenue Growth (YoY)	-100%	-100%	200%	-98%	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	11	10	12	13	4	4
Research & Development	21	22	23	19	21	23
Operating Expenses	32	33	35	33	26	28
Other Non Operating Income (Expenses)	0	0	11	49	0	0
Pretax Income	-34	-35	-22	15	14	-29
Income Tax Expense	--	--	--	0	0	0
Net Income	-34	-35	-22	15	0	-14
Net Income Growth	-3%	59%	-247%	--	-100%	--
Shares Outstanding (Diluted)	4.08	2.18	1.64	1.62	1.62	1.62
Shares Change (YoY)	143%	33%	1%	0%	0%	--
EPS (Diluted)	-8.48	-16.37	-13.76	9.71	0.1	-8.74
EPS Growth	-60%	19%	-242%	9,610%	-101%	--
Free Cash Flow	-29	-29	-26	-24	13	-27
Free Cash Flow Per Share	-7.1	-13.26	-15.78	-14.75	7.99	-16.59
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	-1,066.66%	-3,100%	35.71%	0%
Profit Margin	0%	0%	-733.33%	1,500%	0%	0%
Free Cash Flow Margin	0%	0%	-866.66%	-2,400%	30.95%	0%
EBITDA	-32	-33	-32	-31	15	-28
EBITDA Margin	0%	0%	-1,066.66%	-3,100%	35.71%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-32	-33	-32	-31	15	-28
EBIT Margin	0%	0%	-1,066.66%	-3,100%	35.71%	0%
Effective Tax Rate	--	--	--	0%	0%	0%

eFFECTOR Therapeutics Inc (EFTR) Price